|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 9/24 |
| (11) | Patento numeris | 1716232 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05713310.0 |
| Europos patento paraiškos padavimo data | 2005-02-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-11-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2010-04-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2005/004286 |
| Data | 2005-02-10 |
| (87) | Numeris | WO 2005/078077 |
| Data | 2005-08-25 |
| (30) | Numeris | Data | Šalis |
| 543812 P | 2004-02-10 | US |
| (72) |
LEBOWITZ, Jonathan, US
MAGA, John, US
|
| (73) |
ZyStor Therapeutics , Inc.,
10437 Innovation Drive, Suite 100, Milwaukee, WI 53226-4838,
US
|
| (54) | ACID ALPHA-GLUCOSIDASE AND FRAGMENTS THEREOF |
| ACID ALPHA-GLUCOSIDASE AND FRAGMENTS THEREOF |